Thanks for the confirmation ..this is in line with what Redman and the filings have been saying..they held up trials due to shortage of Prolanta and now with funding in hand have started to manufacture more Prolanta to continue the trials. To me it was more important to know that there were more patients available for the trials since some posters here were making negative comments about the fact that only three patients were available and enrolled. Next week will be interesting with possible ticker change and updates.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.